Sensus Healthcare to Present at The Microcap Conference 2025

Audio By Carbonatix

BOCA RATON, Fla.--(BUSINESS WIRE)--Jan 23, 2025--

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced its participation in The Microcap Conference 2025 being held January 28-30, 2025, in Atlantic City, N.J.

Management will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments, growth strategy, and investment opportunities.

Event: The Microcap Conference 2025
Location: Studio 2, Borgata Hotel Casino & Spa
Date: Thursday, January 30, 2025
Time: 2:00 PM Eastern Time

Investors interested in meeting with management can register for the conference here.

About Sensus Healthcare

Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250123064157/en/

CONTACT: Alliance Advisors IR

Tirth T. Patel

[email protected]

212-201-6614

KEYWORD: FLORIDA NEW JERSEY UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: RADIOLOGY HEALTH ONCOLOGY MEDICAL DEVICES

SOURCE: Sensus Healthcare, Inc.

Copyright Business Wire 2025.

PUB: 01/23/2025 08:00 AM/DISC: 01/23/2025 08:00 AM

http://www.businesswire.com/news/home/20250123064157/en